Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Neoplasms of the CNS

Free Subscription 12.08.2024 1 Acta Neuropathol 1 AJNR Am J Neuroradiol 3 BMC Cancer 1 Br J Cancer 1 Clin Neuropathol 3 J Clin Oncol 8 J Neurooncol 4 Neuro Oncol 1 Neurology 1 Neuroradiology 2 Neurosurgery 2 Oncogene 1 Pediatr Hematol Oncol 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. MAAS SLN, Hielscher T, Sievers P, Hovestadt V, et al
   Loss over 5% of chromosome 1p is a clinically relevant and applicable cut-off for increased risk of recurrence in meningioma.
   Acta Neuropathol. 2024;148:17.
   PubMed        
   
   

   
   AJNR Am J Neuroradiol

2. HEYN C, Bishop J, Moody AR, Kang T, et al
   Gadolinium Enhanced T2 FLAIR is an Imaging Biomarker of Radiation Necrosis and Tumor Progression in Patients with Brain Metastases.
   AJNR Am J Neuroradiol. 2024 Aug 6:ajnr.A8431. doi: 10.3174/ajnr.A8431.
   PubMed         Abstract available
   
   

   
   BMC Cancer

3. YU J, Fu J, Li Y, Hu G, et al
   Hypopituitarism after gamma knife radiosurgery for pituitary adenomas: long-term results from a single-center experience.
   BMC Cancer. 2024;24:963.
   PubMed         Abstract available
   
   
4. WEI R, Zhou J, Bui B, Liu X, et al
   Glioma actively orchestrate a self-advantageous extracellular matrix to promote recurrence and progression.
   BMC Cancer. 2024;24:974.
   PubMed         Abstract available
   
   
5. YAO N, Qin Z, Chen M, Hu L, et al
   Effects of brain radiotherapy strategies on survival in the era of MRI for patients with limited stage small cell lung cancer.
   BMC Cancer. 2024;24:953.
   PubMed         Abstract available
   
   

   
   Br J Cancer

6. ROA P, Foglizzo V, Harada G, Repetto M, et al
   Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents.
   Br J Cancer. 2024;131:601-610.
   PubMed         Abstract available
   
   

   
   Clin Neuropathol

7. ZHOU Y, Wu Y, Shen D, Wang Q, et al
   Evaluation of ST6Gal1 expression and clinicopathological significance in human glioma.
   Clin Neuropathol. 2024 Aug 9. doi: 10.5414/NP301631.
   PubMed         Abstract available
   
   

   
   J Clin Oncol

8. JENG MY, Yu HA
   Leptomeningeal Metastasis in the Era of CNS-Penetrant Tyrosine Kinase Inhibitor Therapy.
   J Clin Oncol. 2024;42:2727-2730.
   PubMed        
   
   
9. PARK S, Baldry R, Jung HA, Sun JM, et al
   Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM).
   J Clin Oncol. 2024 Jun 3:JCO2400708. doi: 10.1200/JCO.24.00708.
   PubMed         Abstract available
   
   
10. LIN FY, Stuckert A, Tat C, White M, et al
    Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.
    J Clin Oncol. 2024;42:2769-2779.
    PubMed         Abstract available
    
    

    
    J Neurooncol

11. WANG B, Qiu B, Deng X
    Comment on the paper: Wang B, Liu Y, Zhang J, Yin S, Liu B, Ding S, Qiu B, Deng X. Evaluating contouring accuracy and dosimetry impact of current MRI-guided adaptive radiation therapy for brain metastases: a retrospective study. J Neurooncol 167(1):12
    J Neurooncol. 2024 Aug 7. doi: 10.1007/s11060-024-04791.
    PubMed        
    
    
12. 
    Imaging timing after surgery for glioblastoma: an evaluation of practice in Great Britain and Ireland (INTERVAL-GB)- a multi-centre, cohort study.
    J Neurooncol. 2024 Aug 6. doi: 10.1007/s11060-024-04705.
    PubMed         Abstract available
    
    
13. BELTRAN-BLESS AA, Alshamsan B, Jia J, Lo V, et al
    Perception of pneumocystis jirovecii pneumonia (PJP) prophylaxis in glioma patients receiving concurrent temozolomide and radiation- a patient and physician survey.
    J Neurooncol. 2024 Aug 6. doi: 10.1007/s11060-024-04764.
    PubMed         Abstract available
    
    
14. RILINGER RG, Guo L, Sharma A, Volovetz J, et al
    Tumor-related epilepsy in high-grade glioma: a large series survival analysis.
    J Neurooncol. 2024 Aug 5. doi: 10.1007/s11060-024-04787.
    PubMed         Abstract available
    
    
15. OHNO M, Takahashi M, Yanagisawa S, Osawa S, et al
    Development of a scoring system to predict local recurrence in brain metastases following complete resection and observation.
    J Neurooncol. 2024 Aug 5. doi: 10.1007/s11060-024-04790.
    PubMed         Abstract available
    
    
16. LEE M, Karschnia P, Park YW, Choi K, et al
    Comparative analysis of molecular and histological glioblastomas: insights into prognostic variance.
    J Neurooncol. 2024 Aug 8. doi: 10.1007/s11060-024-04737.
    PubMed         Abstract available
    
    
17. XU H, Cao Y, Ruan J, Wang F, et al
    The effects of BMP2 and the mechanisms involved in the invasion and angiogenesis of IDH1 mutant glioma cells.
    J Neurooncol. 2024 Aug 8. doi: 10.1007/s11060-024-04789.
    PubMed         Abstract available
    
    
18. KITE T, Shepard MJ
    Comment on "Amino-acid PET as a prognostic tool after post-stupp protocol temozolomide therapy in high-grade glioma patients".
    J Neurooncol. 2024 Aug 9. doi: 10.1007/s11060-024-04796.
    PubMed        
    
    

    
    Neuro Oncol

19. BUDHIRAJA S, McManus G, Baisiwala S, Perrault EN, et al
    ARF4-mediated retrograde trafficking as a driver of chemoresistance in glioblastoma.
    Neuro Oncol. 2024;26:1421-1437.
    PubMed         Abstract available
    
    
20. KARSCHNIA P, Tonn JC
    Shaping the future of molecular neurosurgery: Toward epigenetic precision in surgical neuro-oncology?
    Neuro Oncol. 2024;26:1355-1356.
    PubMed        
    
    
21. WELLER M, Albert NL, Galldiks N, Bink A, et al
    Targeted radionuclide therapy for gliomas: emerging clinical trial landscape.
    Neuro Oncol. 2024 Aug 6:noae125. doi: 10.1093.
    PubMed         Abstract available
    
    
22. MONTOYA M, Collins SA, Chuntova P, Patel TS, et al
    IRF8-driven reprogramming of the immune microenvironment enhances anti-tumor adaptive immunity and reduces immunosuppression in murine glioblastoma.
    Neuro Oncol. 2024 Aug 8:noae149. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neurology

23. ABOUBAKR O, Houillier C, Alentorn A, Choquet S, et al
    Epilepsy in Patients With Primary CNS Lymphoma: Prevalence, Risk Factors, and Prognostic Significance.
    Neurology. 2024;103:e209748.
    PubMed         Abstract available
    
    

    
    Neuroradiology

24. INDORIA A, Kulanthaivelu K, Prasad C, Srinivas D, et al
    Radiomics features for the discrimination of tuberculomas from high grade gliomas and metastasis: a multimodal study.
    Neuroradiology. 2024 Aug 5. doi: 10.1007/s00234-024-03435.
    PubMed         Abstract available
    
    

    
    Neurosurgery

25. MORSHED RA, Nguyen MP, Youngblood MW, Perlow HK, et al
    Gene Expression Changes Associated With Recurrence After Gross Total Resection of Newly Diagnosed World Health Organization Grade 1 Meningioma.
    Neurosurgery. 2024 Aug 5. doi: 10.1227/neu.0000000000003133.
    PubMed         Abstract available
    
    
26. KUMARIA A
    Commentary: Gene Expression Changes Associated With Recurrence After Gross Total Resection of Newly Diagnosed World Health Organization Grade 1 Meningioma.
    Neurosurgery. 2024 Aug 8. doi: 10.1227/neu.0000000000003144.
    PubMed        
    
    

    
    Oncogene

27. HU J, Li X, Xu K, Chen J, et al
    CircVPS8 promotes the malignant phenotype and inhibits ferroptosis of glioma stem cells by acting as a scaffold for MKRN1, SOX15 and HNF4A.
    Oncogene. 2024 Aug 4. doi: 10.1038/s41388-024-03116.
    PubMed         Abstract available
    
    
28. SONG Y, Zhang Y, Wang Z, Lin Y, et al
    CCL2 mediated IKZF1 expression promotes M2 polarization of glioma-associated macrophages through CD84-SHP2 pathway.
    Oncogene. 2024 Aug 7. doi: 10.1038/s41388-024-03118.
    PubMed         Abstract available
    
    

    
    Pediatr Hematol Oncol

29. ROSSI F, Botti S, Morri M, Asaftei S, et al
    The Italian Consensus Conference on the role of rehabilitation for children and adolescents with leukemia, central nervous system tumors, and bone cancer, part 2: general principles for the rehabilitation treatment of motor function impairments.
    Pediatr Hematol Oncol. 2024;41:346-366.
    PubMed         Abstract available
    
    

    
    PLoS One

30. MUKWADA G, Chamunyonga C, Rowshanfarzad P, Gill S, et al
    Insights into the dosimetric and geometric characteristics of stereotactic radiosurgery for multiple brain metastases: A systematic review.
    PLoS One. 2024;19:e0307088.
    PubMed         Abstract available
    
    
31. D S CS, Clement J C
    G-Net: Implementing an enhanced brain tumor segmentation framework using semantic segmentation design.
    PLoS One. 2024;19:e0308236.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.